{
  "id": "mhgap#screening_cues_827ab00f",
  "content": "▶ assist with the scale-up of care for MNS disorders Systematic evidence reviews were used to develop\nidentified as conditions of high priority in LMICs; and the Evidence to Decision and Summary of Findings\n▶ facilitate implementation of WHO action plans tables, according to the Grading of Recommendations\nincluding the Comprehensive mental health action Assessment, Development and Evaluations (GRADE)\nplan 2021–2030, the Intersectoral global action approach. The GDG developed recommendations that\nplan on epilepsy and other neurological disorders considered a range of elements, namely: the certainty\n2022–2031, the Global action plan on the public of the evidence; the balance between desirable and\nhealth response to dementia 2017–2025, and the undesirable effects; values and preferences of intended\nGlobal alcohol action plan 2022–2030 by health-care users of the intervention; resource requirements\nplanners and programme managers in LMICs. and cost-effectiveness; health equity, equality and\nnon-discrimination; feasibility; human rights and\nsociocultural acceptability.\nxvii\nMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders\nWhen making a strong recommendation, the GDG was should receive it, while conditional recommendations\nconfident that the desirable effects of the intervention imply that different choices may be appropriate for",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "screening_cues",
      "referral"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues ▶ assist with the scale-up of care for MNS disorders Systematic evidence reviews were used to develop\nidentified as conditions of high priority in LMICs; and the Evidence to Decision and Summary of Findings\n▶ facilitate implementation of WHO action plans tables, according to the Grading of Recommendations\nincluding the Comprehensive mental health action Assessment, Development and Evaluations (GRADE)\nplan 2021–2030, the Intersectoral global action approach. The GDG developed recommendations that\nplan on epilepsy and other neurological disorders considered a range of elements, namely: the certainty\n2022–2031, the Global action plan on the public of the evidence; the balance between desirable and\nhealth response to dementia 2017–2025, and the undesirable effects; values and preferences of intended\nGlobal alcohol action plan 2022–2030 by health-care users of the intervention; resource requirements\nplanners and programme managers in LMICs. and cost-effectiveness; health equity, equality and\nnon-discrimination; feasibility; human rights and\nsociocultural acceptability.\nxvii\nMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders\nWhen making a strong recommendation, the GDG was should receive it, while conditional recommendations\nconfident that the desirable effects of the intervention imply that different choices may be appropriate for ▶ assist with the scale-up of care for mns disorders systematic evidence reviews were used to develop\nidentified as conditions of high priority in lmics; and the evidence to decision and summary of findings\n▶ facilitate ..."
}